How research reactors help make medical imaging possible

• Autores: Aleksandra Peeva, Nicole Jawerth
• Localización: Organismo Internacional de Energía Atómica Boletin, ISSN 0534-7297, Vol. 60, Nº. 4, 2019, págs. 12-13
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • More than 80% of the medical imaging used each year to diagnose diseases like cancer is made possible by the pharmaceutical drugs produced, for the most part, in research reactors. These radiopharmaceuticals contain the radioisotope technetium-99m (99mTc ), which comes from the radioisotope molybdenum-99 (99Mo) that is primarily produced in research reactors.